Asthma treatment with budesonide formoterol and immune tablets
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if adding immune-modulating tablets (Staphylococcus and Neisseria) to standard asthma medication (budesonide formoterol) helps control asthma better. It is for people whose asthma is not well controlled despite current treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years old or older
- You have had asthma for at least 6 months
- Your asthma is not well controlled (partly or poorly controlled according to guidelines)
- In the last 6 months, a lung function test showed airway narrowing that improves with medication or is triggered by exercise or other stimuli
- You have not used certain immune-modulating drugs (like thymosin, interferon, or bacterial extracts) in the past 30 days
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether starting treatment with a combination anti-inflammatory and reliever inhaler can help people with new, mild asthma control their symptoms better. It compares different treatment strategies to find the best approach for early asthma care.
This trial studies how stepping up asthma treatment affects asthma control in people with mild to moderate asthma. You may be asked to use study inhalers correctly and track symptoms and lung tests to see if control improves.
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
This study tests a new way to treat asthma flares in children and teens (ages 6–18) with mild-to-moderate asthma. It aims to see if a quick-relief anti-inflammatory medicine works better than current treatments to prevent severe attacks.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.